Global Cholesterol Testing Market

NEW YORK, June 10, 2015 /PRNewswire/ -- This report analyzes the worldwide markets for Cholesterol Testing in Million Units by the following Product Segments: Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Apolipoprotein Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 32 companies including many key and niche players such as -

Abbott Diagnostics, Inc.

AccuTech, LLC

Alere Inc.

Beckman Coulter, Inc.

Chek Diagnostics

Read the full report: http://www.reportlinker.com/p02438209-summary/view-report.html

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

A. Lipid Panel Test/Complete Lipid Profile I-3

Total Cholesterol Test I-3

HDL Cholesterol Test I-3

LDL Cholesterol Testing I-3

Triglycerides/VLDL Cholesterol Testing I-4

B. Apolipoprotein B I-4

C. Other Apolipoprotein Tests I-4

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1

Cholesterol Testing - An Overview II-1

Current & Future Analysis II-2

Increasing Healthcare Expenditure to Promote Testing Market II-2

Table 1: Per-Capita Healthcare Expenditure in US$ for Select

Regions (2013) (includes corresponding Graph/Chart) II-3

Developing Economies Offer Significant Potential II-3

Table 2: Healthcare Spending as Percentage of GDP in Select

Developing Countries (2012) (includes corresponding

Graph/Chart) II-4

Table 3: Healthcare Spending as Percentage of GDP in SelectDeveloped Countries for 2004, 2008 & 2012 (includescorresponding Graph/Chart) II-4

2. TRENDS, DRIVERS & CHALLENGES II-5

Global Menace of Cardiovascular Disease - Major Growth Factor II-5

Table 4: Global Annual Medical Cost of CVD in US$ Billion

(2010-2030) (includes corresponding Graph/Chart) II-5

Table 5: Fatalities by Heart Conditions - EstimatedPercentage Breakdown for Cardiovascular Disease, IschemicHeart Disease, Stroke, and Others (includes correspondingGraph/Chart) II-5

Table 6: Fatalities in Low Income Countries by Health

Disorder (2015 & 2030): Projected Percentage Breakdown of

Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria;

Malnutrition; and Others (includes corresponding Graph/Chart) II-6

Table 7: Fatalities in Mid Income Countries by HealthDisorder (2015 & 2030): Projected Percentage Breakdown ofNumber of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria;Malnutrition; and Others (includes corresponding Graph/Chart) II-7

Table 8: Fatalities in High Income Countries by Health

Disorder (2015 & 2030): Projected Percentage Breakdown of

Number of Deaths for CVD, Cancer, Injury, and Others

(includes corresponding Graph/Chart) II-8

Preventive Healthcare Trend to Expand Growth II-8

Technological Advances to Improve Cholesterol Testing II-8

Cholesterol Testing With Smartphone II-9

Growing Smartphone Sales - A Business Case II-9

Table 9: Top Ten Countries by Mobile Subscriptions in

Millions (2012) (includes corresponding Graph/Chart) II-10

Table 10: World Smartphone Market: Sales in Million Units byGeographic Region/Country for 2013 & 2017 (includescorresponding Graph/Chart) II-11Non-Invasive Cholesterol Tests to Drive Demand II-11Digital Photographs to Screen Cholesterol? II-11Miniature Sensors - The Future of Cholesterol Testing II-12Natriuretic Peptides (BNP and NT-proBNP) - New Cardiac Markers II-12The Rise of C-reactive Protein Tests II-13Global In-Vitro Diagnostics Market Signals Prospects II-13Table 11: Global In-Vitro Diagnostics Market by Test Category(2013): Percentage Breakdown of Value Sales for AnatomicPathology, Blood Screen Immunoassay, Coagulation, Hematology,Immunoassay, Microbiology, Molecular Diagnostics,Point-of-Care Diagnostics, and Others (includes correspondingGraph/Chart) II-14

Table 12: Global In-Vitro Diagnostics Market by Sector

(2013): Percentage Breakdown of Revenues for Decentralized &

Patient Self-Testing, and Hospital & Commercial Laboratories

(includes corresponding Graph/Chart) II-15

Table 13: Global Market for In-Vitro Diagnostics byGeographic Region (2013): Percentage Share Breakdown of ValueSales for Asia-Pacific (Excl. Japan), EMEA, Japan, LatinAmerica and North America (includes correspondingGraph/Chart) II-15Cardiac IVD Market Offers Potential II-15POC Testing: Potential Opportunities Ahead II-16Complexities in the POC Diagnostics Market II-16Aging Population - A Vital Demography for Cholesterol Testing II-16Table 14: Global Population Statistics for 65+ Age Group(Male & Female) for Major Countries/Regions (2013) (includescorresponding Graph/Chart) II-17

Table 15: Global Life Expectancy at Age 60 and 80 Years -

(2010-2015), (2020-2025) & (2045-2050) (includes

corresponding Graph/Chart) II-18

Risk of CVD in Obesity Offers Prospects for Cholesterol Testing II-18

Table 16: Global Obese Population in Millions by Region/

Country (2013) (includes corresponding Graph/Chart) II-19

Table 17: Global Obesity Levels (2013): Percentage Share

Breakdown of Total Obese Population by Leading Countries

(includes corresponding Graph/Chart) II-20

Diabetics at Higher Risk of Heart Diseases II-20

Table 18: Worldwide Prevalence of Diabetes Mellitus by

Geographic Region (2013 & 2035P) (includes corresponding

Graph/Chart) II-21

The Hypertension-Cholesterol Link to Drive Demand II-21

Table 19: Death Rates Due to Hypertension in Select

Countries: 2011 II-22

Table 20: Percentage Prevalence Rate of High Blood Pressurefor Patients over 25 Years of Age by Region (1980 & 2010)(includes corresponding Graph/Chart) II-24E-Retailing Drives Demand for Home Test Kits II-24Table 21: Factors Influencing Online Purchase Decision -Percentage Share Breakdown of Consumer Preferences byCriteria (includes corresponding Graph/Chart) II-25

3. AN INSIGHT INTO CARDIOVASCULAR DISEASES II-26

The Heart of Heart Problems II-26

Types of Cardiovascular Diseases/Disorders II-26

Coronary Artery Disease II-26

Hyperlipidemia - An Important Risk Factor of Heart Disease II-26

Hypertension - The Silent Killer II-27

Two-Pronged Approach to Counter CVD II-28

Cardiovascular Risk Assessment II-28

Reality Check II-28

4. GOOD & BAD OF CHOLESTEROL II-29Blood Cholesterol - The Principal Cardiac Risk Marker II-29Types of Cholesterol II-29Total Cholesterol (TC) II-29High Density Lipoprotein (HDL) II-29Low Density Lipoprotein (LDL) / Very Low Density Lipoprotein(VLDL) II-30Triglycerides (TRG) II-30Glucose (GLU) II-30Alanine Aminotransferase (ALT) II-30Outcomes of High Blood Cholesterol II-30Atherosclerosis II-30Coronary Heart Disease (CHD) II-30Risk Factors and Risk Levels II-30Risk Factors II-30Risk Levels II-31Risk Level Based on Total Cholesterol Concentration II-31LDL-Cholesterol Risk Levels II-31HDL-Cholesterol Risk Levels II-31Triglyceride Risk Levels II-31

5. CHOLESTEROL TESTING & CVD RISK ASSESSMENT TECHNIQUES II-32

Cholesterol Testing II-32

Need for Cholesterol Testing II-32

Candidates for Cholesterol Testing II-32

Test Procedure II-33

Time of Testing - Crucial for Heart Disease Patients II-33

Types of Cholesterol Testing II-34

Lipid Panel Test/Lipid Profile II-34

Total Cholesterol Test II-34

HDL Cholesterol Test II-35

LDL Cholesterol Testing II-35

LDL Cholesterol Test - The First Cholesterol Testing Method II-35

Triglycerides/VLDL Cholesterol Testing II-36

Apolipoprotein B Test II-36

Other Cholesterol Tests II-36

Apolipoprotein A-1 Test II-36

ApoE Genotyping Test II-36

Apolipoprotein CII II-36

Other Key Markers for Cholesterol Testing II-37

RLP Cholesterol II-37

Non Instrumented Technologies II-37

Heart Disease Diagnosis Tests II-37

Non-Invasive Tests II-37

Invasive Tests II-38

Other CVD Markers II-38

Creatine Kinase MB II-38

Troponin T and Troponin I II-38

Myoglobin II-39

P-selectin Profile II-39

C-reactive Protein II-39

Endothelial Dysfunction II-40

Homocysteine II-40

Plasminogen Activator Inhibitor-1 II-40

s-100 Protein II-41

Thrombus Precursor Protein II-41

Other Cardiac Markers II-41

6. POINT OF CARE & HOME CHOLESTEROL TESTING II-42Point of Care (POC) Medical Diagnostics II-42Table 22: Global Point of Care Diagnostics Market by Segment(2013): Percentage Breakdown of Revenues for Commercial Labs,Hospital Labs, Point of Care and Self Testing (includescorresponding Graph/Chart) II-42POC Testing Market II-43Table 23: Global Point-of-Care Diagnostics Market by POCTests (2013 & 2015): Percentage Share Breakdown of Revenuesfor Blood Chemistry, Cardiac Markers, Cholesterol, Drug &Alcohol, Glucose Monitoring, Hemoglobin, Tumor Markers, andOthers (includes corresponding Graph/Chart) II-43Development of Home Cholesterol Testing Kits II-43Cholesterol and Other Cardiovascular Test Kits Offered bySelect Companies II-44

7. CHOLESTEROL CONTROL & TREATMENT MODALITIES II-45

Prevention is better than Cure II-45

Dietary Therapy II-45

Healthy Diet II-45

Exercises II-46

Drug Therapy II-46

Classification of Cholesterol Lowering Drugs II-46

Bile Acid Sequestrants II-46

Nicotinic Acid II-46

HMG CoA Reductase Inhibitors (Statins) II-47

Other Drugs (Fibric Acids and Probucol) II-47

Testing After Commencing Drug Therapy II-47

8. PRODUCT INTRODUCTIONS/INNOVATIONS II-48CODIX Introduces SelexOn™ II-48Health Canada Approves Abbott's ARCHITECT STAT High SensitiveTroponin-I Assay II-48PTS Unveils CardioChek® Plus II-48ACON Introduces Mission® Systems II-48Everist Genomics to Unveil AngioDefender II-48Pathway Genomics Introduces InsightSM II-48Boston Heart Diagnostics Unveils SLCO1B1 Genotype Test II-48diaDexus Unveils PLAC® Test in Europe II-48

9. RECENT INDUSTRY ACTIVITY II-49

PTS Switches Name to Chek Diagnostics II-49

LipoScience Parts Ways with Health Diagnostics II-49

Miraculins and Citizen Doctor Sign Distribution Deal II-49

Akers Biosciences Signs Distribution Deal for Rapid Tests in

Australia, Singapore & Middle East II-49

ITC Nexus Acquires Accumetrics II-49

MedTest Signs Deal to Take Over Pointe Scientific II-49

Response Biomedical Signs Deal for Sales Representation with

Med Tech/Med Care II-49

Corgenix Partners Health Diagnostic Laboratory II-50

LipoScience Commences Clinical Development of NMR Diagnostics II-50

Harbert Takes Over Cardioscan II-50

BG Medicine Signs Deal with Kindstar Diagnostics to Offer

Galectin-3 Testing Services II-50

10. FOCUS ON SELECT PLAYERS II-51Abbott Diagnostics, Inc. (US) II-51AccuTech, LLC (US) II-51Alere Inc. (US) II-51Beckman Coulter, Inc. (US) II-52Chek Diagnostics (US) II-53F. Hoffmann-La Roche Ltd (Switzerland) II-53Home Access Health Corporation (US) II-54Siemens Healthcare (Germany) II-54

11. GLOBAL MARKET PERSPECTIVE II-55

Table 24: World Recent Past, Current & Future Analysis for

Cholesterol Testing by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Tests in

Millions for Years 2013 through 2020 (includes corresponding

Graph/Chart) II-55

Table 25: World Historic Review for Cholesterol Testing byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World MarketsIndependently Analyzed with Annual Tests in Millions for Years2006 through 2012 (includes corresponding Graph/Chart) II-56

Table 26: World 15-Year Perspective for Cholesterol Testing by

Geographic Region - Percentage Breakdown of Tests for US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets for Years 2006, 2014 & 2020

(includes corresponding Graph/Chart) II-57

Market by Test Type II-58

Table 27: World Recent Past, Current & Future Analysis for

Lipid Panel/Complete Lipid Profile Tests by Geographic Region -

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets Independently Analyzed

with Annual Tests in Millions for Years 2013 through 2020

(includes corresponding Graph/Chart) II-58

Table 28: World Historic Review for Lipid Panel/ CompleteLipid Profile Tests by Geographic Region - US, Canada, Japan,Europe, Asia-Pacific (excluding Japan), Latin America and Restof World Markets Independently Analyzed with Annual Tests inMillions for Years 2006 through 2012 (includes correspondingGraph/Chart) II-59

Table 29: World 15-Year Perspective for Lipid Panel/Complete

Lipid Profile Tests by Geographic Region - Percentage

Breakdown of Tests for US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets for

Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) II-60

Table 30: World Recent Past, Current & Future Analysis forApolipoprotein B Tests by Geographic Region - US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), Latin Americaand Rest of World Markets Independently Analyzed with AnnualTests in Millions for Years 2013 through 2020 (includescorresponding Graph/Chart) II-61

Table 31: World Historic Review for Apolipoprotein B Tests by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets

Independently Analyzed with Annual Tests in Millions for Years

2006 through 2012 (includes corresponding Graph/Chart) II-62

Table 32: World 15-Year Perspective for Apolipoprotein B Testsby Geographic Region - Percentage Breakdown of Tests for US,Canada, Japan, Europe, Asia-Pacific (excluding Japan), LatinAmerica and Rest of World Markets for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) II-63

Table 33: World Recent Past, Current & Future Analysis for

Other Cholesterol Tests by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Tests in Millions for Years 2013 through 2020 (includes

corresponding Graph/Chart) II-64

Table 34: World Historic Review for Other Cholesterol Tests byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World MarketsIndependently Analyzed with Annual Tests in Millions for Years2006 through 2012 (includes corresponding Graph/Chart) II-65

Table 35: World 15-Year Perspective for Other Cholesterol

Tests by Geographic Region - Percentage Breakdown of Tests for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2006, 2014 &

2020 (includes corresponding Graph/Chart) II-66

III. MARKET

1. THE UNITED STATES III-1

A.Market Analysis III-1

Outlook III-1

Surge in CVD Incidence - Major Growth Factor III-1

Table 36: CVD in the US: Cardiovascular Disease Prevalence

in Adults by Gender & Age Group (includes corresponding

Graph/Chart) III-1

Table 37: CVD in the US: Cardiovascular Disease Incidenceby Gender & Age Group (per 1,000 Adults) (includescorresponding Graph/Chart) III-2

Table 38: Leading Causes of CVD Fatalities in the US:

Percentage Breakdown of Mortality for Coronary Heart

Disease, HBP, Heart Failure, Stroke, and Others (includes

corresponding Graph/Chart) III-2

Ageing Population - Vital Demography III-2

Table 39: North American Elderly Population by Age Group:

1975-2050 (includes corresponding Graph/Chart) III-3

The Risk of CVD in Chronic Conditions to Drive Testing Market III-3

Opportunity Indicators III-4

Table 40: Obesity Prevalence in US Adults by Type of

Obesity (2013) (includes corresponding Graph/Chart) III-4

Table 41: Obesity Prevalence in the US by Age Group (2013)(includes corresponding Graph/Chart) III-4

Table 42: Obesity Prevalence in the US by Percentage

Annual Income Level (2013) (includes corresponding

Graph/Chart) III-4

Table 43: US Diabetics Population (2010-2017): PercentagePopulation with Diagnosed and Undiagnosed Diabetes(includes corresponding Graph/Chart) III-5Table 44: Diabetes Prevalence in the US by Type (2013) (includes corresponding Graph/Chart) III-5Table 45: High Blood Pressure Prevalence in the US (2012):Prevalence Rates for Male and Female Population by AgeGroups (includes corresponding Graph/Chart) III-6

Table 46: High Blood Pressure Prevalence in the US (2012):

Prevalence Rates for Male and Female Population by Ethnic

Group (includes corresponding Graph/Chart) III-6

Increasing Cardiovascular Ailments Drive Sales of Home Test

Devices III-7

Cholesterol POCT Market: An Overview III-7

Cholesterol Testing - NCEP Recommendations Spurs Potential III-7

Innovations Drive the Usage of Cardiovascular Monitoring

Systems III-7

Sterols and Stanols: Cholesterol-Lowering Products III-8

Product Launches III-8

Strategic Corporate Developments III-9

Key Players III-10

B.Market Analytics III-13

Table 47: US Recent Past, Current & Future Analysis for

Cholesterol Testing by Test Type - Lipid Panel Test/Complete

Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests

Independently Analyzed with Annual Tests in Thousands for

Years 2013 through 2020 (includes corresponding Graph/Chart) III-13

Table 48: US Historic Review for Cholesterol Testing by TestType - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-14

Table 49: US 15-Year Perspective for Cholesterol Testing by

Test Type - Percentage Breakdown of Tests for Lipid Panel

Test/Complete Lipid Profile, Apolipoprotein B, and Other

Cholesterol Tests for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-15

2. CANADA III-16A.Market Analysis III-16Outlook III-16Product Launch III-16B.Market Analytics III-17Table 50: Canadian Recent Past, Current & Future Analysisfor Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-17

Table 51: Canadian Historic Review for Cholesterol Testing

by Test Type - Lipid Panel Test/Complete Lipid Profile,

Apolipoprotein B, and Other Cholesterol Tests Independently

Analyzed with Annual Tests in Thousands for Years 2006

through 2012 (includes corresponding Graph/Chart) III-18

Table 52: Canadian 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-19

3. JAPAN III-20

Market Analysis III-20

Table 53: Japanese Recent Past, Current & Future Analysis

for Cholesterol Testing by Test Type - Lipid Panel

Test/Complete Lipid Profile, Apolipoprotein B, and Other

Cholesterol Tests Independently Analyzed with Annual Tests

in Thousands for Years 2013 through 2020 (includes

corresponding Graph/Chart) III-20

Table 54: Japanese Historic Review for Cholesterol Testingby Test Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-21

Table 55: Japanese 15-Year Perspective for Cholesterol

Testing by Test Type - Percentage Breakdown of Tests for

Lipid Panel Test/ Complete Lipid Profile, Apolipoprotein B,

and Other Cholesterol Tests for Years 2006, 2014 & 2020

(includes corresponding Graph/Chart) III-22

4. EUROPE III-23A.Market Analysis III-23Outlook III-23Product Launch III-23B.Market Analytics III-24Table 56: European Recent Past, Current & Future Analysisfor Cholesterol Testing by Geographic Region - France,Germany, Italy, UK, Spain, Russia, and Rest of EuropeMarkets Independently Analyzed with Annual Tests inThousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-24

Table 57: European Historic Review for Cholesterol Testing

by Geographic Region - France, Germany, Italy, UK, Spain,

Russia, and Rest of Europe Markets Independently Analyzed

with Annual Tests in Thousands for Years 2006 through 2012

(includes corresponding Graph/Chart) III-25

Table 58: European 15-Year Perspective for CholesterolTesting by Geographic Region - Percentage Breakdown of Testsfor France, Germany, Italy, UK, Spain, Russia, and Rest ofEurope Markets for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-26

Table 59: European Recent Past, Current & Future Analysis

for Cholesterol Testing by Test Type - Lipid Panel

Test/Complete Lipid Profile, Apolipoprotein B, and Other

Cholesterol Tests Independently Analyzed with Annual Tests

in Thousands for Years 2013 through 2020 (includes

corresponding Graph/Chart) III-27

Table 60: European Historic Review for Cholesterol Testingby Test Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-28

Table 61: European 15-Year Perspective for Cholesterol

Testing by Test Type - Percentage Breakdown of Tests for

Lipid Panel Test/ Complete Lipid Profile, Apolipoprotein B,

and Other Cholesterol Tests for Years 2006, 2014 & 2020

(includes corresponding Graph/Chart) III-29

4a. FRANCE III-30Market Analysis III-30Table 62: French Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-30

Table 63: French Historic Review for Cholesterol Testing by

Test Type - Lipid Panel Test/Complete Lipid Profile,

Apolipoprotein B, and Other Cholesterol Tests Independently

Analyzed with Annual Tests in Thousands for Years 2006

through 2012 (includes corresponding Graph/Chart) III-31

Table 64: French 15-Year Perspective for Cholesterol Testingby Test Type - Percentage Breakdown of Tests for Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-32

4b. GERMANY III-33

A.Market Analysis III-33

Outlook III-33

Siemens Healthcare - Key German Player III-33

B.Market Analytics III-34

Table 65: German Recent Past, Current & Future Analysis for

Cholesterol Testing by Test Type - Lipid Panel Test/Complete

Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests

Independently Analyzed with Annual Tests in Thousands for

Years 2013 through 2020 (includes corresponding Graph/Chart) III-34

Table 66: German Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-35

Table 67: German 15-Year Perspective for Cholesterol Testing

by Test Type - Percentage Breakdown of Tests for Lipid Panel

Test/Complete Lipid Profile, Apolipoprotein B, and Other

Cholesterol Tests for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-36

4c. ITALY III-37Market Analysis III-37Table 68: Italian Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-37

Table 69: Italian Historic Review for Cholesterol Testing by

Test Type - Lipid Panel Test/Complete Lipid Profile,

Apolipoprotein B, and Other Cholesterol Tests Independently

Analyzed with Annual Tests in Thousands for Years 2006

through 2012 (includes corresponding Graph/Chart) III-38

Table 70: Italian 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-39

4d. THE UNITED KINGDOM III-40

Market Analysis III-40

Table 71: UK Recent Past, Current & Future Analysis for

Cholesterol Testing by Test Type - Lipid Panel Test/Complete

Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests

Independently Analyzed with Annual Tests in Thousands for

Years 2013 through 2020 (includes corresponding Graph/Chart) III-40

Table 72: UK Historic Review for Cholesterol Testing by TestType - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-41

Table 73: UK 15-Year Perspective for Cholesterol Testing by

Test Type - Percentage Breakdown of Tests for Lipid Panel

Test/Complete Lipid Profile, Apolipoprotein B, and Other

Cholesterol Tests for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-42

4e. SPAIN III-43Market Analysis III-43Table 74: Spanish Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-43

Table 75: Spanish Historic Review for Cholesterol Testing by

Test Type - Lipid Panel Test/Complete Lipid Profile,

Apolipoprotein B, and Other Cholesterol Tests Independently

Analyzed with Annual Tests in Thousands for Years 2006

through 2012 (includes corresponding Graph/Chart) III-44

Table 76: Spanish 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-45

4f. RUSSIA III-46

Market Analysis III-46

Table 77: Russian Recent Past, Current & Future Analysis for

Cholesterol Testing by Test Type - Lipid Panel Test/Complete

Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests

Independently Analyzed with Annual Tests in Thousands for

Years 2013 through 2020 (includes corresponding Graph/Chart) III-46

Table 78: Russian Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-47

Table 79: Russian 15-Year Perspective for Cholesterol

Testing by Test Type - Percentage Breakdown of Tests for

Lipid Panel Test/ Complete Lipid Profile, Apolipoprotein B,

and Other Cholesterol Tests for Years 2006, 2014 & 2020

(includes corresponding Graph/Chart) III-48

4g. REST OF EUROPE III-49A.Market Analysis III-49Outlook III-49Product Launch III-49F. Hoffmann-La Roche Ltd. - A Key Swiss Player III-49B.Market Analytics III-50Table 80: Rest of Europe Recent Past, Current & FutureAnalysis for Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-50

Table 81: Rest of Europe Historic Review for Cholesterol

Testing by Test Type - Lipid Panel Test/Complete Lipid

Profile, Apolipoprotein B, and Other Cholesterol Tests

Independently Analyzed with Annual Tests in Thousands for

Years 2006 through 2012 (includes corresponding Graph/Chart) III-51

Table 82: Rest of Europe 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-52

5. ASIA-PACIFIC III-53

A.Market Analysis III-53

The Largest Market Worldwide III-53

B.Market Analytics III-54

Table 83: Asia-Pacific Recent Past, Current & Future

Analysis for Cholesterol Testing by Geographic Region -

China, India, and Rest of Asia-Pacific Markets Independently

Analyzed with Annual Tests in Thousands for Years 2013

through 2020 (includes corresponding Graph/Chart) III-54

Table 84: Asia-Pacific Historic Review for CholesterolTesting by Geographic Region - China, India, and Rest ofAsia-Pacific Markets Independently Analyzed with AnnualTests in Thousands for Years 2006 through 2012 (includescorresponding Graph/Chart) III-55

Table 85: Asia-Pacific 15-Year Perspective for Cholesterol

Testing by Geographic Region - Percentage Breakdown of Tests

for China, India, and Rest of Asia-Pacific Markets for Years

2006, 2014 & 2020 (includes corresponding Graph/Chart) III-56

Table 86: Asia-Pacific Recent Past, Current & FutureAnalysis for Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-57

Table 87: Asia-Pacific Historic Review for Cholesterol

Testing by Test Type - Lipid Panel Test/Complete Lipid

Profile, Apolipoprotein B, and Other Cholesterol Tests

Independently Analyzed with Annual Tests in Thousands for

Years 2006 through 2012 (includes corresponding Graph/Chart) III-58

Table 88: Asia-Pacific 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-59

5a. CHINA III-60

A.Market Analysis III-60

Outlook III-60

Corporate Development III-60

B.Market Analytics III-61

Table 89: Chinese Recent Past, Current & Future Analysis for

Cholesterol Testing by Test Type - Lipid Panel Test/Complete

Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests

Independently Analyzed with Annual Tests in Thousands for

Years 2013 through 2020 (includes corresponding Graph/Chart) III-61

Table 90: Chinese Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-62

Table 91: Chinese 15-Year Perspective for Cholesterol

Testing by Test Type - Percentage Breakdown of Tests for

Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B,

and Other Cholesterol Tests for Years 2006, 2014 & 2020

(includes corresponding Graph/Chart) III-63

5b. INDIA III-64A.Market Analysis III-64Outlook III-64Corporate Development III-64B.Market Analytics III-65Table 92: Indian Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-65

Table 93: Indian Historic Review for Cholesterol Testing by

Test Type - Lipid Panel Test/Complete Lipid Profile,

Apolipoprotein B, and Other Cholesterol Tests Independently

Analyzed with Annual Tests in Thousands for Years 2006

through 2012 (includes corresponding Graph/Chart) III-66

Table 94: Indian 15-Year Perspective for Cholesterol Testingby Test Type - Percentage Breakdown of Tests for Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-67

5c. REST OF ASIA-PACIFIC III-68

A.Market Analysis III-68

Outlook III-68

Corporate Development III-68

B.Market Analytics III-69

Table 95: Rest of Asia-Pacific Recent Past, Current & Future

Analysis for Cholesterol Testing by Test Type - Lipid Panel

Test/Complete Lipid Profile, Apolipoprotein B, and Other

Cholesterol Tests Independently Analyzed with Annual Tests

in Thousands for Years 2013 through 2020 (includes

corresponding Graph/Chart) III-69

Table 96: Rest of Asia-Pacific Historic Review forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2006 through 2012 (includes corresponding Graph/Chart) III-70

Table 97: Rest of Asia-Pacific 15-Year Perspective for

Cholesterol Testing by Test Type - Percentage Breakdown of

Tests for Lipid Panel Test/Complete Lipid Profile,

Apolipoprotein B, and Other Cholesterol Tests for Years

2006, 2014 & 2020 (includes corresponding Graph/Chart) III-71

6. LATIN AMERICA III-72Market Analysis III-72Table 98: Latin American Recent Past, Current & FutureAnalysis for Cholesterol Testing by Geographic Region -Brazil, and Rest of Latin America Markets IndependentlyAnalyzed with Annual Tests in Thousands for Years 2013through 2020 (includes corresponding Graph/Chart) III-72

Table 99: Latin American Historic Review for Cholesterol

Testing by Geographic Region - Brazil, and Rest of Latin

America Markets Independently Analyzed with Annual Tests in

Thousands for Years 2006 through 2012 (includes

corresponding Graph/Chart) III-73

Table 100: Latin American 15-Year Perspective forCholesterol Testing by Geographic Region - PercentageBreakdown of Tests for Brazil, and Rest of Latin AmericaMarkets for Years 2006, 2014 & 2020 (includes correspondingGraph/Chart) III-74

Table 101: Latin American Recent Past, Current & Future

Analysis for Cholesterol Testing by Test Type - Lipid Panel

Test/Complete Lipid Profile, Apolipoprotein B, and Other

Cholesterol Tests Independently Analyzed with Annual Tests

in Thousands for Years 2013 through 2020 (includes

corresponding Graph/Chart) III-75

Table 102: Latin American Historic Review for CholesterolTesting by Test Type - Lipid Panel Test/Complete LipidProfile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2006 through 2012 (includes corresponding Graph/Chart) III-76

Table 103: Latin American 15-Year Perspective for

Cholesterol Testing by Test Type - Percentage Breakdown of

Tests for Lipid Panel Test/Complete Lipid Profile,

Apolipoprotein B, and Other Cholesterol Tests for Years

2006, 2014 & 2020 (includes corresponding Graph/Chart) III-77

6a. BRAZIL III-78Market Analysis III-78Table 104: Brazilian Recent Past, Current & Future Analysisfor Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-78

Table 105: Brazilian Historic Review for Cholesterol Testing

by Test Type - Lipid Panel Test/Complete Lipid Profile,

Apolipoprotein B, and Other Cholesterol Tests Independently

Analyzed with Annual Tests in Thousands for Years 2006

through 2012 (includes corresponding Graph/Chart) III-79

Table 106: Brazilian 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-80

6b. REST OF LATIN AMERICA III-81

Market Analysis III-81

Table 107: Rest of Latin America Recent Past, Current &

Future Analysis for Cholesterol Testing by Test Type - Lipid

Panel Test/Complete Lipid Profile, Apolipoprotein B, and

Other Cholesterol Tests Independently Analyzed with Annual

Tests in Thousands for Years 2013 through 2020 (includes

corresponding Graph/Chart) III-81

Table 108: Rest of Latin America Historic Review forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2006 through 2012 (includes corresponding Graph/Chart) III-82

Table 109: Rest of Latin America 15-Year Perspective for

Cholesterol Testing by Test Type - Percentage Breakdown of

Tests for Lipid Panel Test/Complete Lipid Profile,

Apolipoprotein B, and Other Cholesterol Tests for Years

2006, 2014 & 2020 (includes corresponding Graph/Chart) III-83

7. REST OF WORLD III-84Market Analysis III-84Table 110: Rest of World Recent Past, Current & FutureAnalysis for Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-84

Table 111: Rest of World Historic Review for Cholesterol

Testing by Test Type - Lipid Panel Test/Complete Lipid

Profile, Apolipoprotein B, and Other Cholesterol Tests

Independently Analyzed with Annual Tests in Thousands for

Years 2006 through 2012 (includes corresponding Graph/Chart) III-85

Table 112: Rest of World 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-86IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 32 (including Divisions/Subsidiaries - 37)

The United States (29)Canada (1)Japan (1)Europe (4)- Germany (1)- The United Kingdom (2)- Rest of Europe (1)Asia-Pacific (Excluding Japan) (2)

Read the full report: http://www.reportlinker.com/p02438209-summary/view-report.html

About Reportlinker

 ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

Related Links

http://www.reportlinker.com